COMMODORE CAPITAL LP - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 23, 2023, COMMODORE CAPITAL LP's relationship to Enliven Therapeutics, Inc. (ELVN) is TenPercentOwner, and currently has 1,448,640 shares of Common stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ELVN insiders.
Data Source: SEC.
COMMODORE CAPITAL LP - Insider Non-Derivative Transactions at ELVN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 24, 2023 | P -- (Common stock, par value $0.001 per share) | 621.75 | 22.07 | 718749 |
| Feb 24, 2023 | J -- (Common stock, par value $0.001 per share) | 729891 | 0 | 1448640 |